Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novosanis

Novosanis
2013 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer of medical devices intended to improve the quality of diagnostics tests as well as the accuracy of drug delivery. The company's devices range from injection appliances to in vitro diagnostic accessories that are suited for collection of first void urine which provides an improved diagnosis of sexually transmitted infections and cancer, enabling physicians to treat their patients in an enhanced way.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Diagnostic Equipment
Parent Company
Primary Office
  • Bijkhoevelaan 32c
  • 2110 Wijnegem
  • Belgium

+32 03 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Novosanis’s full profile, request a free trial.

Novosanis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 04-Jan-2019 00000 Completed Generating Revenue
4. Grant 04-Apr-2017 00000 Completed Generating Revenue
3. Grant 15-Sep-2015 00000 Completed Generating Revenue
2. Grant 13-Aug-2014 $336K $636K Completed Generating Revenue
1. Seed Round 19-Jul-2013 $636K $636K 00.000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Novosanis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Class B 00,000 000.00 000.00 00 000.00 00.000
To view this company’s complete Cap Table, request access »

Novosanis Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mindera Venture Capital-Backed San Diego, CA 0 00.000 00000000000 00.000
000000000000 Venture Capital-Backed Saint Louis, MO 00 0000 0000000000 0 0000
00000000 000000 Venture Capital-Backed York, United Kingdom 00 000.00 0000000000 0 000.00
00000000 Private Equity-Backed Espoo, Finland 000 000.00 000000000 000.00
00000 0000000 Venture Capital-Backed Saint Paul, MN 00 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Novosanis Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Horizon 2020 Government Minority 000 0000 000000 0
Taste Westerlund Venture Capital Minority 000 0000 000000 0

Novosanis Executive Team (5)

Name Title Board
Seat
Contact
Info
Vanessa Vankerckhoven Ph.D Co-Founder, Chief Executive Officer & Board Member
Koen Beyers Co-Founder, Chief Technology Officer & Board Member

3 Former Executives

You’re viewing 2 of 5 executives. Get the full list »

Novosanis Board Members (8)

Name Representing Role Since Contact
Info
Alex Vorsters Ph.D Novosanis Member of Board of Directors and Chairman of Scientific Advisory Board Colli-Pee 000 0000
Koen Beyers Novosanis Co-Founder, Chief Technology Officer & Board Member 000 0000
Luc Kindt Novosanis Board Member & Advisor, Sales 000 0000
Philip De Mulder Novosanis Board Member 000 0000
Pierre Van Damme Novosanis Chairman of the Board of Director 000 0000

1 Former Board Member

You’re viewing 5 of 8 board members. Get the full list »